Fennec Pharmaceuticals Inc.(FENC)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FENC Fennec Pharmaceuticals Inc.

未开盘 08-15 16:00:00 EDT

5.58

+0.25

+4.69%

盘后5.58

+0.000.00%

16:20 EDT

最高5.58	最低5.37	成交量6.73万
今开5.47	昨收5.33	日振幅3.94%
总市值1.53亿	流通市值7,416万	总股本2,736万
成交额36.77万	换手率0.51%	流通股本1,329万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"FENC","market":"US","secType":"STK","nameCN":"Fennec Pharmaceuticals Inc.","latestPrice":5.58,"timestamp":1723752000000,"preClose":5.33,"halted":0,"volume":67338,"hourTrading":{"tag":"盘后","latestPrice":5.58,"preClose":5.58,"latestTime":"16:20 EDT","volume":39,"amount":217.62,"timestamp":1723753200317},"delay":0,"floatShares":13289705,"shares":27364335,"eps":-0.070516,"marketStatus":"未开盘","marketStatusCode":0,"change":0.25,"latestTime":"08-15 16:00:00 EDT","open":5.47,"high":5.58,"low":5.37,"amount":367653.406297,"amplitude":0.0394,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.070516,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1723795200000},"adr":0,"adjPreClose":5.33,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":5.47,"preClose":5.33,"latestTime":"09:29 EDT","volume":272,"amount":1492.1599856,"timestamp":1723728599999},"postHourTrading":{"tag":"盘后","latestPrice":5.58,"preClose":5.58,"latestTime":"16:20 EDT","volume":39,"amount":217.62,"timestamp":1723753200317},"volumeRatio":0.510614,"impliedVol":1.6354,"impliedVolPercentile":0.9127},"requestUrl":"/m/hq/s/FENC","defaultTab":"news","newsList":[{"id":"2459110388","title":"Fennec Pharmaceuticals Inc.盘中异动 早盘股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459110388","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459110388?lang=zh_cn&edition=full","pubTime":"2024-08-14 22:39","pubTimestamp":1723646359,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日22时39分，Fennec Pharmaceuticals Inc.股票出现异动，股价急速跳水5.21%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Zura Bio Limited C/Wts 、Newamsterdam Pharma Co Nv C/Wts 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Genprex, Inc.、Conduit Pharmaceuticals Inc.、Tc Biopharm  Plc较为活跃，换手率分别为84.58%、70.92%、60.69%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Genprex, Inc.、Tc Biopharm  Plc，振幅分别为60.83%、58.52%、49.86%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814223919aefec0e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814223919aefec0e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"gpt_icon":0},{"id":"2459110671","title":"美国研究综述-Agenus、Guardant Health、Zoetis","url":"https://stock-news.laohu8.com/highlight/detail?id=2459110671","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459110671?lang=zh_cn&edition=full","pubTime":"2024-08-14 14:49","pubTimestamp":1723618162,"startTime":"0","endTime":"0","summary":"    路透8月14日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 Agenus、Guardant Health 和 Zoetis。要闻              * Agenus Inc   ：B. Riley将目标价从42美元下调至18美元             * Clorox   ：杰富瑞将目标价从 148 美元上调至 151 美元             * Guardant Health Inc   ：Raymond James将目标价从28美元上调至36美元             * 星巴克  ：Stifel将其评级从 \"持有 \"上调至 \"买入\"；将目标价从80美元上调至110美元             * Zoetis Inc   ：Piper Sandler将目标价从195美元上调至210美元 以下是路透周三报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU","FE","GH","AIZ","CTNM","AMCX","FEMY","SKY","EIX","MO","CMS","LU2506952410.USD","AEP","LU2506952337.HKD","LU0942090050.USD","ALUR","CLX","LU2211815571.USD","EMR","D","DUK","BHF","ATKR","HD","CNP","ES","ADVM","LU0149725797.USD","WTRG","IBTA","BALL","ED","AGEN","CPK","ANNX","BKH","HEI","AWK","BOLD","SLRN","LU0205193047.USD","IDXX","FENC","LU1363072403.SGD","ETR","EXC","FTHM"],"gpt_icon":1},{"id":"2459507901","title":"Fennec Pharmaceuticals Inc.盘中异动 股价大跌13.84%报5.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459507901","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459507901?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:32","pubTimestamp":1723555938,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日21时32分，Fennec Pharmaceuticals Inc.股票出现波动，股价快速跳水13.84%。截至发稿，该股报5.39美元/股，成交量2.0822万股，换手率0.08%，振幅6.40%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408132132189f278dd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408132132189f278dd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"gpt_icon":0},{"id":"2458543941","title":"Fennec Pharmaceuticals Inc   预计每股亏损 3 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2458543941","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458543941?lang=zh_cn&edition=full","pubTime":"2024-08-10 03:25","pubTimestamp":1723231513,"startTime":"0","endTime":"0","summary":"   * Fennec Pharmaceuticals Inc    将于8月13日公布截至2024年6月30日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，6位分析师的平均预期显示，这家总部位于北卡罗来纳州三角研究园的公司的营收有望从去年同期的333万美元增长232.3%，达到1104.9万美元。* LSEG 分析师对 Fennec Pharmaceuticals Inc 的平均预期是每股亏损 3 美分。* 华尔街对 Fennec Pharmaceuticals Inc 的 12 个月目标价中位数为 16.50 美元，高于其最新收盘价 6.08 美元。8月9日 - 以往季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Fennec Pharmaceuticals Inc   预计每股亏损 3 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FENC"],"gpt_icon":0},{"id":"2457268098","title":"Fennec Pharmaceuticals Inc.盘中异动 大幅拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457268098","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457268098?lang=zh_cn&edition=full","pubTime":"2024-08-07 23:37","pubTimestamp":1723045071,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日23时37分，Fennec Pharmaceuticals Inc.股票出现异动，股价急速拉升5.15%。截至发稿，该股报5.92美元/股，成交量2.4933万股，换手率0.09%，振幅3.55%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为1.99%。其相关个股中，Aditxt, Inc.、G1 Therapeutics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Aditxt, Inc.、Salarius Pharmaceuticals, Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为4462.36%、1045.41%、326.10%，振幅较大的相关个股有Aditxt, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Salarius Pharmaceuticals, Inc.，振幅分别为101.30%、69.66%、47.31%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807233751af966bf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807233751af966bf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"gpt_icon":0},{"id":"2457775528","title":"Fennec Pharmaceuticals Inc.盘中异动 早盘急速下跌6.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457775528","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457775528?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:32","pubTimestamp":1722864779,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时32分，Fennec Pharmaceuticals Inc.股票出现波动，股价急速跳水6.07%。截至发稿，该股报5.41美元/股，成交量1099股，换手率0.00%，振幅0.00%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为1.36%。其相关个股中，Zevra Therapeutics, Inc.、Alzamend Neuro, Inc.、Cns Pharmaceuticals, Inc.涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为982.49%、35.53%、13.54%，振幅较大的相关个股有Vor Biopharma Inc.、Compass Therapeutics, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为13.04%、12.19%、11.60%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080521325996823eef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080521325996823eef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"gpt_icon":0},{"id":"2456282675","title":"Fennec Pharmaceuticals Inc.盘中异动 早盘快速下挫5.25%报5.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456282675","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456282675?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:43","pubTimestamp":1722606209,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时43分，Fennec Pharmaceuticals Inc.股票出现波动，股价快速跳水5.25%。截至发稿，该股报5.94美元/股，成交量3181股，换手率0.01%，振幅0.96%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Exicure, Inc.、Os Therapies Incorporated、Dermata Therapeutics, Inc.涨幅较大，Dermata Therapeutics, Inc.、Exicure, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为940.63%、465.39%、35.52%，振幅较大的相关个股有Os Therapies Incorporated、Exicure, Inc.、Dermata Therapeutics, Inc.，振幅分别为54.19%、44.23%、37.50%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802214329af95a6ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802214329af95a6ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"gpt_icon":0},{"id":"2455967490","title":"Fennec Pharmaceuticals Inc   预计每股亏损 3 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2455967490","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455967490?lang=zh_cn&edition=full","pubTime":"2024-07-31 03:36","pubTimestamp":1722368196,"startTime":"0","endTime":"0","summary":"   * Fennec Pharmaceuticals Inc    预计将在8月1日公布截至2024年6月30日的业绩(估计)，季度收入将有所增长。* 根据LSEG的数据，6位分析师的平均预期显示，这家总部位于北卡罗来纳州三角研究园的公司的营收有望从去年同期的333万美元增长232.3%，达到1104.9万美元。* LSEG 分析师对 Fennec Pharmaceuticals Inc 的平均预期是每股亏损 3 美分。* 华尔街对 Fennec Pharmaceuticals Inc 的 12 个月目标价中位数为 16.50 美元，高于其最新收盘价 6.27 美元。7月30日 - 以前季度业绩。除非另有说明，所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FENC"],"gpt_icon":0},{"id":"2435636492","title":"HC Wainwright & Co.：维持Fennec Pharmaceuticals(FENC.US)评级，由买入调整至买入评级, 目标价由18.00美元调整至15.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435636492","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435636492?lang=zh_cn&edition=full","pubTime":"2024-05-15 19:16","pubTimestamp":1715771795,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：维持Fennec Pharmaceuticals(FENC.US)评级，由买入调整至买入评级, 目标价由18.00美元调整至15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405151916378b0b1f18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405151916378b0b1f18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC"],"gpt_icon":0},{"id":"2435166595","title":"Fennec Pharmaceuticals(FENC.US)：2024年Q1财报实现营收2537.7万美元，前值为167.","url":"https://stock-news.laohu8.com/highlight/detail?id=2435166595","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435166595?lang=zh_cn&edition=full","pubTime":"2024-05-14 18:26","pubTimestamp":1715682393,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["FENC","BK4139"],"gpt_icon":0},{"id":"2433896457","title":"Fennec Pharmaceuticals Inc   预计每股收益26美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433896457","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433896457?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:55","pubTimestamp":1715093752,"startTime":"0","endTime":"0","summary":"   * Fennec Pharmaceuticals Inc    预计将在5月9日公布截至2024年3月31日的业绩(估计)，季度收入将有所增长。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于北卡罗来纳州三角研究园的公司的营收有望从去年同期的168万美元增长1025.6%，达到1887.6万美元。* LSEG 分析师对 Fennec Pharmaceuticals Inc 的平均预期为每股收益 26 美分。* 华尔街对 Fennec Pharmaceuticals Inc 的 12 个月目标价中位数为 18.00 美元，高于其最新收盘价 9.09 美元。5月7日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FENC"],"gpt_icon":0},{"id":"2428373010","title":"Fennec Pharmaceuticals Inc.盘中异动 股价大跌5.07%报9.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428373010","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2428373010?lang=zh_cn&edition=full","pubTime":"2024-04-18 03:54","pubTimestamp":1713383670,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日03时54分，Fennec Pharmaceuticals Inc.股票出现波动，股价快速下跌5.07%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.54%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家临床阶段的生物技术公司。消息层面，截至03时54分，《Form 144 | Fennec Pharmaceuticals高管拟出售2.22万股股份，价值约22.88万美元》资讯为影响Fennec Pharmaceuticals Inc.的重要信息。该信息摘要如下：根据美国证券交易委员会美东时间4月15日披露的文件，$Fennec Pharmaceuticals $高管ADRIAN J HAIGH拟于4月15日出售2.22万股普通股股份，总市值约22.88万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404180354307921482f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404180354307921482f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"gpt_icon":0},{"id":"2424361991","title":"HC Wainwright &amp; Co.：维持Fennec Pharmaceuticals(FENC.US)评级，由买入调整至买入评级, 目标价由17.","url":"https://stock-news.laohu8.com/highlight/detail?id=2424361991","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2424361991?lang=zh_cn&edition=full","pubTime":"2024-04-04 18:21","pubTimestamp":1712226096,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","FENC"],"gpt_icon":0},{"id":"2421830006","title":"Fennec Pharmaceuticals Inc.2023财年实现净利润-16.05百万美元，同比增加32.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421830006","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2421830006?lang=zh_cn&edition=full","pubTime":"2024-03-22 06:18","pubTimestamp":1711059495,"startTime":"0","endTime":"0","summary":"12月31日，Fennec Pharmaceuticals Inc.公布财报，公告显示公司2023财年净利润为-16.05百万美元，同比增加32.31%；其中营业收入为21.25百万美元，同比增加1279.87%，每股基本收益为-0.60美元。机构评级：截至2023年12月31日，当前有4家机构对Fennec Pharmaceuticals Inc.目标价做出预测，其中目标均价为16.50美元，其中最低目标价为16.00美元，最高目标价为18.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403220618178b528895&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403220618178b528895&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC"],"gpt_icon":0},{"id":"2421049234","title":"Fennec Pharmaceuticals(FENC.US)：2023年Q4财报实现营收973.5万美元，前值为153.","url":"https://stock-news.laohu8.com/highlight/detail?id=2421049234","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2421049234?lang=zh_cn&edition=full","pubTime":"2024-03-21 22:09","pubTimestamp":1711030192,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","FENC"],"gpt_icon":0},{"id":"2415052618","title":"Fennec Pharmaceuticals Inc.盘中异动 早盘股价大涨6.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2415052618","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2415052618?lang=zh_cn&edition=full","pubTime":"2024-02-29 22:44","pubTimestamp":1709217865,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日22时44分，Fennec Pharmaceuticals Inc.股票出现异动，股价快速拉升6.87%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为1.04%。其相关个股中，Carmell Corp C/Wts 12/07/2028 、Enveric Biosciences, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Enveric Biosciences, Inc.、Adial Pharmaceuticals, Inc、Scisparc Ltd.较为活跃，换手率分别为2057.91%、114.77%、54.18%，振幅较大的相关个股有Carmell Corp C/Wts 12/07/2028 、Enveric Biosciences, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为81.15%、51.74%、34.76%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402292244267915f927&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402292244267915f927&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fennecpharma.com","stockEarnings":[{"period":"1week","weight":-0.0822},{"period":"1month","weight":-0.1709},{"period":"3month","weight":-0.2074},{"period":"6month","weight":-0.3807},{"period":"1year","weight":-0.3042},{"period":"ytd","weight":-0.5027}],"compareEarnings":[{"period":"1week","weight":0.0423},{"period":"1month","weight":-0.0209},{"period":"3month","weight":0.0446},{"period":"6month","weight":0.1072},{"period":"1year","weight":0.258},{"period":"ytd","weight":0.1636}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fennec Pharmaceuticals Inc.最初是作为一家英属哥伦比亚公司成立的，其名称是“粘着”技术公司，随后于2014年9月3日改名。Fennec和它的全资子公司氧化奎特公司(“氧化物”)和Fennec制药公司，以及加拿大的一家加拿大公司(简称“CBI”)，在这里被统称为“公司”，是一家生物制药公司，有一个正在开发中的产品，用于治疗癌症。该公司是一家生物制药公司，主要关注硫代硫酸钠(“STS”)的开发，以预防小儿癌症患者体内铂中毒的毒性。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":-0.012234},{"month":2,"riseRate":0.571429,"avgChangeRate":0.018842},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.020679},{"month":4,"riseRate":0.571429,"avgChangeRate":-0.021313},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.031154},{"month":6,"riseRate":0.428571,"avgChangeRate":0.018884},{"month":7,"riseRate":0.714286,"avgChangeRate":0.031531},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.050678},{"month":9,"riseRate":0.666667,"avgChangeRate":0.058778},{"month":10,"riseRate":0.428571,"avgChangeRate":0.012399},{"month":11,"riseRate":0.714286,"avgChangeRate":-0.002651},{"month":12,"riseRate":0.571429,"avgChangeRate":0.038013}],"exchange":"NASDAQ","name":"Fennec Pharmaceuticals Inc.","nameEN":"Fennec Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fennec Pharmaceuticals Inc.(FENC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fennec Pharmaceuticals Inc.(FENC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fennec Pharmaceuticals Inc.,FENC,Fennec Pharmaceuticals Inc.股票,Fennec Pharmaceuticals Inc.股票老虎,Fennec Pharmaceuticals Inc.股票老虎国际,Fennec Pharmaceuticals Inc.行情,Fennec Pharmaceuticals Inc.股票行情,Fennec Pharmaceuticals Inc.股价,Fennec Pharmaceuticals Inc.股市,Fennec Pharmaceuticals Inc.股票价格,Fennec Pharmaceuticals Inc.股票交易,Fennec Pharmaceuticals Inc.股票购买,Fennec Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fennec Pharmaceuticals Inc.(FENC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fennec Pharmaceuticals Inc.(FENC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况